• Chi-Med announces commercial launch of Elunate biospectrumasia
    November 28, 2018
    Elunate is for the treatment of patients with metastatic colorectal cancer (CRC) that have been previously treated with fluoropyrimidine, oxaliplatin and irinotecan.
PharmaSources Customer Service